ACADEMISCH ZIEKENHUIS MAASTRICHT

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 6119
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 5250
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 5162
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 2238
 
  
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 2105
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
  
 
C07K PEPTIDES 2134
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 1139

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0176,445 METHOD FOR DETERMINING THE LEVEL OF HYPOXIA IN A TUMORFeb 11, 15Jun 22, 17[G01N, C07K]
2016/0160,287 METHOD FOR DETERMINING THE RISK OF DEVELOPING RADIATION-INDUCED TOXICITY AFTER EXPOSURE TO RADIATIONMay 05, 14Jun 09, 16[C12Q, A61N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9822414 In vitro method for predicting in vivo genotoxicity of chemical compoundsMay 19, 12Nov 21, 17[C12Q, G01N]
9790545 Method for determining the neurodevelopmental toxicity of a compound in vitroApr 17, 13Oct 17, 17[C12Q]
9750717 Inhibitors of CD40-TRAF6 interactionFeb 09, 16Sep 05, 17[A61K, C07D, C07C]
9744042 Cranial implantSep 21, 10Aug 29, 17[A61F, A61B]
9611480 Means and methods for counteracting, delaying and/or preventing adverse energy metabolism switches in heart diseaseJul 16, 14Apr 04, 17[C12N]
9528155 In vitro method for determining immunotoxicity of a compoundSep 16, 13Dec 27, 16[C12Q, G01N]
9408829 Inhibitors of CD40-TRAF6 interactionAug 27, 13Aug 09, 16[A61K, A01N, C07D, C07C]
9393303 Methods for treating liver inflammation in a subject suffering from non-alcoholic steatohepatitisFeb 21, 12Jul 19, 16[A61K, A61P, C07K]
9155756 Method for the prevention and treatment of sepsisJul 12, 12Oct 13, 15[A61K, A61P]
8815822 Means and methods for counteracting, delaying and/or preventing adverse energy metabolism switches in heart diseaseAug 06, 09Aug 26, 14[C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0105,342 IN VITRO METHOD FOR PREDICTING DISEASE OUTCOME IN STAGE II COLORECTAL CANCERAbandonedApr 25, 13Apr 16, 15[C12Q]
2015/0071,856 ANTAGONISTIC PEPTIDES FOR FRIZZLED-1 AND FRIZZLED-2AbandonedSep 12, 13Mar 12, 15[C07K]
8628958 Diagnostic and therapeutic tools for diseases altering vascular functionWithdrawnDec 01, 08Jan 14, 14[C12Q, C12N]
8598122 Antagonistic peptides for frizzled-1 and frizzled-2ExpiredFeb 18, 10Dec 03, 13[A61K, C12N, A61P]
2013/0244,896 IN VITRO METHOD FOR PREDICTING WHETHER A COMPOUND IS GENOTOXIC IN VIVOAbandonedMar 14, 13Sep 19, 13[C12Q]
2012/0077,704 METHOD FOR SCREENING COMPOUNDS FOR THE TREATMENT OR PREVENTION OF COLON CANCERAbandonedJun 11, 10Mar 29, 12[C12Q, C40B]
2011/0230,357 METHOD FOR DETERMINING THE PRIMARY SITE OF CUPAbandonedMar 16, 10Sep 22, 11[C12Q, C12M, G06F, C40B]
2011/0151,418 PORTABLE PSYCHOLOGICAL MONITORING DEVICEAbandonedApr 14, 09Jun 23, 11[G09B]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.